42Stockpicking

INVA

Innoviva Inc
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
6,1
4th %ile · 62p
EV/EBITDAi
1,5
16th %ile · 16p
P/Bi
1,2
4th %ile · 64p
P/Si
4,0
59th %ile · 70p
EV/Salesi
2,6
44th %ile · 70p
Div yieldi

Kursudvikling

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 23.6.2026full
Prishistorik
21,7 år
Pris-dage
5462
Årsregnskaber
18
Peers
0/0
Valuation
5/6
Fundamentals
8/8
Datovindue
2004-10-05 til 2026-06-22

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Kør compute-multiples for manglende valuation metrics.

Seneste assessment

INVA vurderet 2026-06-23

Score
61.8%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

61%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

67%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

64%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

77%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

77%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

89%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: Own P/E 6.1 vs peer median 18.3; cheaper than peers if business quality is comparable.

Insider activity

DatoPersonRolleTypeAntalVærdiKilde
20.5.2026Zhen MarianneChief Accounting Officer· ANDET-1.127-25.064 USDsec
20.5.2026Raifeld PavelChief Executive Officer· ANDET-1.130-25.131 USDsec
20.5.2026Basso StephenChief Financial Officer· ANDET-559-12.432 USDsec
18.5.2026Linden Josephine· ANDET5.733sec
15.5.2026Raifeld PavelChief Executive Officer· ANDET1.123sec
15.5.2026Basso StephenChief Financial Officer· ANDET1.123sec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q130.4.20260,470,43+8.8%+8.8%Beat
2025Q430.1.20260,470,43+11.2%+11.2%Beat
2025Q330.10.20250,380,39-0.1%-0.1%Inline
2025Q230.7.20250,770,50+54.0%+54.0%Beat